Skip to main content

Molbio Diagnostics Share Price

MOLBIO

Small Cap | Healthcare

₹ 1483.70

-2.70(0.18%)

Live Molbio Diagnostics Share Price Chart

Molbio Diagnostics Performance

Days Range

Previous Close₹1,486.40
Open₹1,488.00
Volume3,95,696
Day's Range₹1,473.20 - ₹1,541.30
52W Range₹926.35 - ₹1,686.80
Market Cap₹17,109.68 Cr

Molbio Diagnostics Fundamentals

ROCE(TTM)13.62
P/E Ratio (TTM)120.81
P/B Ratio11.88
Industry P/E63.88
Debt to Equity0.27
ROE10.72
EPS (TTM)13.44
Dividend YieldN/A
Book Value125.00
Face Value1
ROCE(TTM)13.62
P/E Ratio (TTM)120.81
P/B Ratio11.88
Industry P/E63.88
Debt to Equity0.27
ROE10.72
EPS (TTM)13.44
Dividend YieldN/A
Book Value125.00
Face Value1

Molbio Diagnostics Financials

Sep 2025Mar 2026Jun 2026Sep 2026
Net Sales580.27560.62408.38259.02
Expenses425.89421.50324.87238.43
Profit before tax147.74131.8375.9117.51
Operating Profit106.8495.8352.747.70
Net Profit106.8495.8352.747.70
EPS in Rs9.748.055.211.33

Molbio Diagnostics Shareholding Pattern

Promoters
41.29%
Retail And Others
38.03%
Foreign Institutional Investors
1.59%
Domestic Institutional Investors
19.09%

About Molbio Diagnostics

Molbio Diagnostics Limited was originally incorporated as Molbio Diagnostics Private Limited' at Panaji, as a Private Company dated October 20, 2000. Thereafter, Company converted from private to a Public limited Company and a fresh Certificate of incorporation dated January 16, 2025 was issued by the RoC. Company is innovative point-of-care (POC) diagnostics company focused on expanding access to accurate, rapid and cost-effective healthcare technologies to diagnose infectious and non-communicable diseases. The Company entered into a joint venture agreement in August, 2011 with Bigtec Innovations Private Limited and Bigtec Private Limited, which started operations in 2000. Bigtec Innovations Private Limited got merged with the Company in 2015. It has developed Truenat' platform in 2015, which is a novel POC polymerase chain reaction (PCR) platform that can operate in resource limited settings since its battery operated, facilitating decentralized diagnosis within an hour. The Company works five manufacturing facilities in India, of which two are in Goa, one in Bengaluru, Karnataka and one in Visakhapatnam, Andhra Pradesh. Company is mainly engaged in the business of manufacturing chip based diagnostic devices, chips and reagents, X-ray equipment's, single / dual detector solutions, developing diagnostic devices, performing tests in the bio-sensing domain, digital pathology, etc. In addition to this, it offer products globally to public health programs, diagnostic laboratories, and private and public hospitals. In February 2023, Company acquired 65.47% of the equity share capital of Prognosys Medical Systems Pvt Ltd to venture into radiology equipment. Further, in October 2024, Company acquired a 19.68 % equity stake in OptraScan Inc., a USA based company, to diversify to digital pathology scanners. The Company came up with the IPO of 11,646,246 equity shares of Rs 1 each and raised funds of Rs 940 crore which comprise a fresh issue of 2,480,246 equity shares amounting to Rs 200 crore and the offer for sale of 9,166,000 equity shares amounting to Rs 740 crore on August 12, 2026. The Company has collaborated with Equine Biotech Private Limited for the development of veterinary diagnostic solutions in 2026.

Parent Organisation
Indian Private
Managing Director
NA
Founded
2000
NSE Symbol
MOLBIO

Molbio Diagnostics Share Price History

Data is not available currently. Please check back later.

Top Mutual Funds Invested in Molbio Diagnostics Share

Data is not available currently. Please check back later.

Peer Comparison

StocksLTP (₹)Market Cap (cr)52 Week Low-High (₹)
Apollo Hospitals Enterprise Ltd8,790.0Price increase
19.00 (0.22%)
₹1,25,900.726,696.5 - 9,070.5
Max Healthcare Institute Ltd1,017.4Price increase
7.50 (0.74%)
₹98,306.03797.0 - 1,185.4
Manipal Health Enterprises Ltd695.3Price increase
4.05 (0.59%)
₹90,984.64597.0 - 815.0
Aster DM Quality Care Ltd733.15Price decrease
-16.85 (-2.25%)
₹65,462.60519.1 - 891.3
Fortis Healthcare Ltd801.95Price decrease
-1.25 (-0.16%)
₹60,502.35704.95 - 1,010.1
Narayana Hrudayalaya Ltd1,899.7Price increase
4.40 (0.23%)
₹38,706.961,589.0 - 2,093.3

Molbio Diagnostics Ltd FAQs

Yes, You can buy Molbio Diagnostics Ltd (MOLBIO) shares by opening a Demat account with Angel One.
Molbio Diagnostics Ltd (MOLBIO) share can be bought through the following modes:
1. Direct investment: You can buy Molbio Diagnostics Ltd (MOLBIO) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Molbio Diagnostics Ltd (MOLBIO) shares.